Scrip
Second Provenge FDA panel review "unlikely"
23 November 2009
Nancy Faigen
Please Login to read the full article.
23 November 2009
Nancy Faigen
The US FDA has accepted for review Dendreon's amended BLA for Provenge (sipuleucel-T), setting a user fee deadline of May 1st, 2010.
Dendreon said that the agency considered the package that will now be reviewed a complete Class II resubmission, following an action letter received by the...
Please Login to read the full article.
RELATED CONTENT
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
